| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911074 | Lung Cancer | 2015 | 6 Pages |
Abstract
Although the survival of patients treated for early-stage NSCLC were good, the OS of the entire cohort of SPLC after HNSCC was poor as a majority of patients presented with advanced disease. The use of CT screening strategies in this patient population warrants further investigation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gwendolyn H.M.J. Griffioen, Alexander V. Louie, Remco de Bree, Egbert F. Smit, Marinus A. Paul, Ben J. Slotman, C. Rene Leemans, Suresh Senan,